Chb-M’ treatment down-regulated the SOS1 protein expression in 7 out of 9 cell lines (77.8%) and significant anti-tumor efficacy was observed in 5 out of 9 cell lines (55.6%). The gene discussed is SOS1; the disease is neoplasm.